Why is the Novo Nordisk stock price volatile?

The stock price has shown some volatility, with significant price movements in response to regulatory and market news related to diabetes and obesity markets. Novo Nordisk operates in the highly competitive and rapidly evolving pharmaceutical industry, specifically in diabetes and obesity markets.

Is Novo Nordisk a good stock to buy?

Novo Nordisk's stock has performed well over the past few years, with a 3-year annualized return of around 23%. The stock price has shown some volatility, with significant price movements in response to regulatory and market news related to diabetes and obesity markets.

Where is Novo Nordisk A/S headquartered?

The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark. View Novo Nordisk A/S Sponsored ADR Class B NVO stock quote prices, financial information, real-time forecasts, and company news from CNN.